However, a recent clinical trial targeting CD147 showed its promise to speed up the recovery of COVID-19 patients25, and different groups had revealed the potential CD147 interaction with SARS-CoV-2 on megakaryocytes, platelets, human CD147 knock-in NSG mice model, and iPSC-derived kidney podocytes model18,19,21,22. Here, BSG is linked to COVID-19.